|
EF-Tu Targeting Antibody for Infection Treatment
Application
Therapeutic monoclonal antibodies directed to Elongation Factor-Tu (EF-Tu) for the treatment of infections.
Key Benefits
An antibody that targets the protein EF-Tu, which is present on many types of bacteria involved in life-threatening infections.
A research-grade antibody has been developed with animal data showing the ability to...
Published: 7/30/2024
Contributor(s): Joanna Goldberg, Dina Moustafa
|
|
Generation of Vaccines Preventing the Common Cold
Application
A new class of vaccines targeting the viruses causing the common cold, rhinoviruses (RV).
Key Benefits
Capsid-chimeric strains for developing new RV vaccines.
Preclinical data with a prototype show the ability to induce a robust capsid-specific immune response.
Straightforward and inexpensive vaccine manufacturing process utilizing...
Published: 10/17/2024
Contributor(s): Sujin Lee
|
|
Serological Test for SARS-CoV-2
Application
Clinical assay for detecting SARS-CoV-2 neutralizing antibodies.
Key Benefits
Highly specific and sensitive.
Fewer false positives than commercially available tests.
Market Summary
SARS-CoV-2 is currently causing a devastating pandemic and there is a pressing need to understand the dynamics, specificity, and neutralizing...
Published: 7/30/2024
Contributor(s): Rafi Ahmed, Mehul Suthar, John Roback, Jens Wrammert, Robert Kauffman
|
